Literature DB >> 15201578

Crohn's disease in the over-60 age group: a population based study.

Denis Heresbach1, Jean-Luc Alexandre, Jean-François Bretagne, Etienne Cruchant, Alain Dabadie, Michèle Dartois-Hoguin, Pierre-Marie Girardot, Hervé Jouanolle, Jean Kerneis, Jean-Claude Le Verger, Véronnique Louvain, Lena Pennognon, Martial Richecoeur, Joseph Politis, Michel Robaszkiewicz, Jacques Arnaud Seyrig, Isabelle Tron.   

Abstract

OBJECTIVES: Late-onset Crohn's disease (CD) may show a distinctive pattern of expression. The aim of our study was to describe the incidence or presentation of CD in the elderly and compare the outcomes in patients < 60 years or > or = 60 years at diagnosis.
METHODS: The study included a population based inception cohort of all incident CD cases diagnosed in Brittany (France) between 1994 and 1997. Sixty-three patients were > or = 60 years and 201 were < 60 years at diagnosis. The physicians managing the patients used standardized questionnaires to collect the study data. The questionnaires on outcomes and treatments were completed in 2002.
RESULTS: In patients > or = 60 years, the annual incidence was 2.5 per 10 persons and clinical features were similar to those in younger patients, except for a higher rate of colon involvement. Among older patients, those with diverticula (29/63, 46%) were more likely to have granulomas (58% vs 33% of patients without diverticula, P < 0.04), but the diagnosis of CD was confirmed by lesions remote from the diverticula in most cases (23/29). Early resection rates were not higher in older patients, who were less likely to require immunosuppressants or re-admission for CD flares, as compared to younger patients. Five year mortality in older patients was 16% but was unrelated to CD.
CONCLUSIONS: In Brittany, the age specific incidence, clinical features, and prognosis of CD among the elderly are comparable to those in younger individuals. Colon involvement is more common. Concomitant diverticular disease is common and should prompt a search for CD lesions at other sites to confirm the diagnosis. Older patients are less likely to require immunosuppressants or admission for flares.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15201578     DOI: 10.1097/01.meg.0000108337.41221.08

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  21 in total

1.  Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study.

Authors:  Tomer Adar; David Faleck; Saranya Sasidharan; Kelly Cushing; Nienke Z Borren; Niharika Nalagatla; Ryan Ungaro; Wayne Sy; Samuel C Owen; Anish Patel; Benjamin L Cohen; Ashwin N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2019-02-17       Impact factor: 8.171

2.  Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT.

Authors:  Siddharth Singh; Larry W Stitt; Guangyong Zou; Reena Khanna; Parambir S Dulai; William J Sandborn; Brian G Feagan; Vipul Jairath
Journal:  Aliment Pharmacol Ther       Date:  2019-03-19       Impact factor: 8.171

3.  Old-age inflammatory bowel disease onset: a different problem?

Authors:  Joaquin Hinojosa del Val
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 4.  Considerations and Changes in the Evaluation, Management, and Outcomes in the Management of Diverticular Disease: The Diagnosis, Pathology, and Treatment of Diverticular Colitis.

Authors:  Robert J Kucejko; Juan L Poggio
Journal:  Clin Colon Rectal Surg       Date:  2018-06-22

Review 5.  Systematic Review and Meta-analysis: Phenotype and Clinical Outcomes of Older-onset Inflammatory Bowel Disease.

Authors:  Ashwin N Ananthakrishnan; Hai Yun Shi; Whitney Tang; Cindy C Y Law; Joseph J Y Sung; Francis K L Chan; Siew C Ng
Journal:  J Crohns Colitis       Date:  2016-02-29       Impact factor: 9.071

6.  Older Age- and Health-related Quality of Life in Inflammatory Bowel Diseases.

Authors:  Gabriella Velonias; Grace Conway; Elizabeth Andrews; John J Garber; Hamed Khalili; Vijay Yajnik; Ashwin N Ananthakrishnan
Journal:  Inflamm Bowel Dis       Date:  2017-02       Impact factor: 5.325

Review 7.  Recent trends in the epidemiology of inflammatory bowel diseases: up or down?

Authors:  Peter-Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

Review 8.  A Comprehensive Review of the Diagnosis and Pharmacological Management of Crohn's Disease in the Elderly Population.

Authors:  David Kim; Sasha Taleban
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

9.  Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel disease.

Authors:  Mirjam Bueno de Mesquita; Marc Ferrante; Liesbet Henckaerts; Marie Joossens; Virginie Janssens; Tibor Hlavaty; Marie Pierik; Sofie Joossens; Nele Van Schuerbeek; Gert Van Assche; Paul Rutgeerts; Severine Vermeire; Ilse Hoffman
Journal:  Eur J Pediatr       Date:  2008-08-01       Impact factor: 3.183

10.  Association of age at diagnosis and Crohn's disease phenotype.

Authors:  Sandra M Quezada; Eileen K Steinberger; Raymond K Cross
Journal:  Age Ageing       Date:  2012-08-22       Impact factor: 10.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.